Table 2:
Contiued
| Sample characteristics | Dialysis characteristics | ||||
|---|---|---|---|---|---|
| Authors, year, country, study design, duration (PMID) [Ref.] | Key enrolment criteria | high flux HD | HDF | high flux HD | HDF |
| Maduell F et al., (ESHOL) 2013, Spain 36 monthsRCT (23411788) [11] | Inclusion: – age >18 years | n. 450 | n. 456 | Dialysis vintage: 27 (12-58) months | Dialysis vintage: 28.5 (12-60) months |
| – 3 t/w standard HD for >3 months | Age: 66.3±14.3 years | Age: 64.5±14.4 years | Duration: 234.1 min (232.2-236.1) | Duration: 235.8 min (234.2-237.3) | |
| Exclusion: | Males: 64.2% | Males: 69.5% | Vascular access: | Vascular access: | |
| – active systemic diseases | AVF: 82.7% | AVF: 89.3% | |||
| – liver cirrhosis, malignancy | Diabetes: 27.1% | Diabetes: 22.8% | Graft: 4.2% | Graft: 3.3% | |
| – immunosuppressive therapy | CVC: 13.1% | CVC: 7.5% | |||
| – dialysis dose (Kt/V<1.3) | Active smokers: NA | Active smokers: NA | |||
| – single needle dialysis | Filter: high flux dialyzers (92%) and low flux dialyzers (8%) | Filter: high flux dialyzers | |||
| – temporary non-tunnelized catheter | Previous CVD: NA | Previous CVD: NA | Infusate volume: 23.7 (23.3 - 24.1) L/session | ||
| Convection strategy baseline: >18 L/session | |||||
NA: not available; RF: replacement fluid; t/w: times per week.